CME Group (CME) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Achieved record Q2 2024 revenue of $1.53 billion, up 13% year-over-year, with the highest-ever adjusted net income of $932 million and adjusted EPS of $2.56, both up 11% from Q2 2023.
Net income rose 14% to $883 million, with diluted EPS at $2.42, and operating margin improved to 69.1%.
Average daily volume (ADV) reached a record 25.9 million contracts, up 14% year-over-year, with broad-based growth across all asset classes and record non-US ADV of 7.8 million contracts, up 23%.
Physical commodities revenue grew 17% year-over-year, representing over one-third of clearing and transaction fees.
Continued innovation with the announcement of a new private Google Cloud region and colocation facility to support global trading and leverage AI/data capabilities.
Financial highlights
Q2 2024 revenue: $1.53 billion, up from $1.36 billion in Q2 2023; net income: $883 million; adjusted net income: $932 million.
Market data revenue increased 7% to $175 million; other revenue rose over 35% to $107 million.
Adjusted operating margin rose to 69.1% from 66.8% a year ago; effective tax rate was 23.1%.
Cash and equivalents at period end were $2.0 billion; total debt was $3.4 billion as of June 30, 2024.
Paid $419 million in dividends during Q2; over $25 billion returned to shareholders since 2012.
Outlook and guidance
Tracking in line with guidance: 1.5%-2% increase in clearing/transaction fees, 3%-5% in data products, and total revenue impact of 2.5%-3% for the year.
Expense guidance for the full year remains unchanged, with expected $60 million increase in the second half due to marketing, technology/cloud migration, and compensation.
No current impact on financial guidance from the new Google colocation facility; future impacts to be layered in as guidance is updated.
Focus remains on capital efficiencies, new product launches, and value creation through Google Cloud partnership for the remainder of 2024.
Management expects to maintain investment grade credit ratings and strong liquidity, with no material changes in market risk exposure since year-end 2023.
Latest events from CME Group
- Q2 2026 saw record revenue, strong market data growth, and robust shareholder returns.CME
Q2 202624 Jul 2026 - Record revenue, earnings, and trading volumes, with strong innovation and capital returns.CME
Q4 202522 Jul 2026 - Record Q1 2026 revenue and net income driven by surging global trading volumes and innovation.CME
Q1 202622 Jul 2026 - S&P 500 ESG Index rebranded as Scores and Screens, fueling growth in liquid ESG investment products.CME
Beyond ESG with Understanding the S&P 500 ESG Index Ecosystem Conference9 Jul 2026 - Strong volumes, new product launches, and tech-driven change shape a dynamic market outlook.CME
Piper Sandler Global Exchange and Trading Conference 20249 Jul 2026 - Director election amendments failed; all nominated directors reelected; no shareholder questions.CME
AGM 20269 Jun 2026 - CFTC's Bitcoin perpetual approval sparks risk warnings amid new product launches and efficiency focus.CME
Piper Sandler Global Exchange and Fintech Conference4 Jun 2026 - Class B Proposals seek to modernize board structure and offer payments to shareholders if approved.CME
Proxy filing19 May 2026 - Board candidates stress governance, risk oversight, and shareholder advocacy for the 2026 meeting.CME
Proxy filing16 Apr 2026